Recent Finacing
Recent Raise
Cara Therapeutics is a commercial-stage biopharmaceutical developing and commercializing therapies for pruritus and pain, including FDA-approved difelikefalin injection, oral difelikefalin programs, CR845, and preclinical cannabinoid candidates.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
